
Professor Maggie Shepherd is a Consultant Nurse and Associate Director for Nursing Research at the Royal Devon University Healthcare NHS Foundation Trust. She is Honorary Clinical Professor of monogenic diabetes at the University of Exeter. She has won national and international awards for her work including the Aster Guardians Global Nurse of the Year 2023.
Her broad research interest is improving patient care through the correct diagnosis and treatment of monogenic diabetes. She has specific interests in improving awareness of monogenic diabetes amongst healthcare professionals through a range of educational initiatives and qualitative research to gain an in-depth understanding of patient perspectives.
This paper focused on identifying monogenic diabetes in children and finding out how common it is:
Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes Shepherd M, Shields B, Hammersley S, Hudson M, McDonald TJ, Colclough K, Oram RA, Knight B, Hyde C, Cox J, Mallam K, Moudiotis C, Smith R, Fraser B, Robertson S, Greene S, Ellard S, Pearson ER, Hattersley AT on behalf of the UNITED team. Diabetes Care. 2016. Nov;39(11):1879-1888.
This paper highlights which patients with monogenic diabetes are most likely to be well managed on sulphonylurea tablets:
A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin Shepherd MH, Shields BM, Hudson M, Pearson ER, Hyde C, Ellard S, Hattersley AT, Patel KA; UNITED study. Diabetologia. 2018 Dec;61(12):2520-2527.
These 3 papers provide insights into the impact of treatment change following the correct genetic diagnosis:
Stopping insulin injections following genetic testing in diabetes: impact on identity Shepherd M. 2010. Diabetic Medicine. 27, 1-6
Transforming lives: transferring patients with neonatal diabetes from insulin to sulphonylureas – Shepherd – 2006 – European Diabetes Nursing Shepherd M. 2006. European Diabetes Nursing. 3, 3, 137-142
‘I don’t feel like a diabetic any more’: the impact of stopping insulin in patients with maturity onset diabetes of the young following genetic testing Shepherd M, Hattersley AT. 2004. Clinical Medicine. 4, 2, 144-147
This paper describes a national initiative to raise awareness of monogenic diabetes amongst healthcare professionals:
Ten years of the national genetic diabetes nurse network: a model for the translation of genetic information into clinical care Shepherd M, Colclough K, Ellard S, Hattersley AT. Clinical Medicine 2014. 14(2):117-21
This paper provides guidance for the management of monogenic diabetes in pregnancy:
Management of sulfonylurea-treated monogenic diabetes in pregnancy: implications of placental glibenclamide transfer Shepherd M, Brook AJ, Chakera AJ, Hattersley AT. Diabet Med. 2017 May 30. doi: 10.1111/dme.13388.
Details about genetic diabetes are available on our website www.diabetesgenes.org with the specific details about diabetes diagnosed in the first 9 months of life https://www.diabetesgenes.org/about-neonatal-diabetes/
Genetic testing for neonatal diabetes is only appropriate for people diagnosed under 9 months, and is not performed if the age of diagnosis is greater than this as after this age the testing is always negative. Most cases under 6 months will have a genetic cause found but it is far less likely between 6-9 months.
Please support the Neonatal diabetes crowdfunding campaign raising money to support genetic testing when patients cannot afford it especially those from low or middle-income countries can be found here: https://exeter.hubbub.net/p/exeterdiabetes/pitch/